Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
N Engl J Med
; 390(12): 1154, 2024 Mar 21.
Article
in En
| MEDLINE
| ID: mdl-38507768
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Spiro Compounds
/
Glomerulosclerosis, Focal Segmental
Limits:
Humans
Language:
En
Journal:
N Engl J Med
/
N. Engl. j. med
/
New England journal of medicine
Year:
2024
Type:
Article
Affiliation country:
China